Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma

Biswas, D. orcid.org/0000-0001-9141-5188, Liu, Y.-H. orcid.org/0009-0001-1508-5276, Herrero, J. orcid.org/0000-0001-7313-717X et al. (267 more authors) (2025) Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma. Nature Cancer, 6. pp. 86-101. ISSN 2662-1347

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: Humans; Adenocarcinoma of Lung; Biomarkers, Tumor; Lung Neoplasms; Prospective Studies; Prognosis; Male; Female; Gene Expression Regulation, Neoplastic; Middle Aged; Aged; Transcriptome; Exome Sequencing
Dates:
  • Published: January 2025
  • Published (online): 9 January 2025
  • Accepted: 15 November 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 14 Mar 2025 11:11
Last Modified: 14 Mar 2025 11:11
Published Version: https://doi.org/10.1038/s43018-024-00883-1
Status: Published
Publisher: Springer Science and Business Media LLC
Refereed: Yes
Identification Number: 10.1038/s43018-024-00883-1
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics